Biotechnology company Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Phase 3 Magnitude trial for transthyretin amyloid cardiomyopathy (ATTR-CM).

U.S. Stocks Move | Oil and gas stocks rise broadly in pre-market trading, Occidental Petroleum (OXY.US) up over 6%

Last week, global listed companies made a net purchase of BTC worth $208.79 million. Strategy invested $204.1 million to acquire 3,015 bitcoins, representing a 412.8% increase compared to the previous week's purchase amount.

ProCap Financial increases holdings by 450 BTC and accelerates share buybacks to narrow NAV discount

According to data from the Federal Reserve Bank of New York, the Secured Overnight Financing Rate (SOFR) was reported at 3.68% on the previous trading day (February 27), compared to 3.67% the day before.